Meisner Derek M

CIK 00017524613 companiesNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001752461

Recent Transactions

50 trades

Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-03-06$1.85/sh+2,090→ 176,089 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-03-06−2,090→ 71,048 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-03-06$3.26/sh−2,090→ 173,999 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-02-27−9,406→ 73,138 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-02-27$3.01/sh−9,406→ 173,999 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-02-27$1.85/sh+9,406→ 183,405 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-28$1.85/sh+2,671→ 176,670 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-28$3.00/sh−2,671→ 173,999 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-01-28−2,671→ 82,544 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-26$1.85/sh+15,085→ 189,084 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-01-26−15,085→ 85,215 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-26$3.00/sh−15,085→ 173,999 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-23$1.90/sh−5,633→ 173,999 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-22$1.84/sh−1,054→ 179,632 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-21$1.81/sh−2,247→ 180,686 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-01-16+148,700→ 148,700 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-16+99,133→ 182,933 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-12$1.71/sh−8,548→ 83,800 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-09$1.76/sh−5,200→ 92,348 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-08$1.82/sh−30,092→ 97,548 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-08$1.82/sh−6,819→ 127,640 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-07$1.99/sh−10,070→ 134,459 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-07$1.99/sh−1,700→ 144,529 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-06$1.97/sh−3,801→ 146,229 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-06$1.97/sh−7,097→ 150,030 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-05$1.96/sh−4,000→ 157,127 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-21$1.59/sh−3,418→ 161,127 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-06+66,800→ 164,545 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2025-01-06+100,300→ 100,300 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-03$1.84/sh−11,122→ 97,745 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-19$3.48/sh−8,933→ 108,867 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2024-01-02+137,000→ 137,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-02+91,000→ 117,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-01-17+26,800→ 26,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2023-01-17+120,800→ 120,800 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2022-09-06+225,000→ 225,000 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-08-17−8,334→ 145,155 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-24−4,166→ 153,489 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-16−4,166→ 157,655 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-03-01+105,000→ 161,821 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-02-11−15,909→ 56,821 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-08-17$5.10/sh−8,332→ 72,730 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-24$7.00/sh−4,166→ 81,062 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-23+12,500→ 85,228 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-15$7.84/sh−4,166→ 72,728 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-06-15+12,500→ 76,894 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2021-03-24+47,728→ 64,394 total
Sale
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-09-09$8.05/sh−8,334→ 16,666 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-08-17+12,500→ 25,000 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2020-08-14+12,500→ 12,500 total

Companies

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov